Clinical Trials on Moderate-severe Skin Aging/Photoaging in Germany
Total 88 results
-
AllerganCompletedModerate to Severe Nasolabial FoldsGermany, Netherlands
-
Diamant ThaciWithdrawnModerate to Severe Plaque PsoriasisGermany
-
IpsenCompletedModerate to Severe Glabellar LinesFrance, Germany
-
UCB Biopharma SRLActive, not recruitingModerate to Severe Plaque PsoriasisUnited States, Canada, Germany, Poland
-
Merz Aesthetics GmbHMerz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Germany
-
Kythera BiopharmaceuticalsBayerCompletedModerate or Severe Submental FullnessBelgium, France, Germany, Italy, Spain, United Kingdom
-
Kythera BiopharmaceuticalsBayerCompletedModerate or Severe Submental FullnessGermany, France, Belgium, Spain, United Kingdom
-
Novartis PharmaceuticalsCompletedModerate and Severe Plaque PsoriasisUnited States, Argentina, Germany, Belgium, Italy, United Kingdom, Turkey, Guatemala, Australia
-
Novartis PharmaceuticalsCompletedModerate to Severe Nail PsoriasisGermany, Belgium, Spain, United States, Australia, United Kingdom, Denmark, Czechia, Greece
-
Regeneron PharmaceuticalsSanofiCompletedModerate to Severe Atopic Hand and Foot DermatitisUnited States, Germany, Japan, Poland
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Estonia, France, Canada
-
Amazentis SAproDERM GmbHCompleted
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Spain, Sweden, Switzerland, United Kingdom
-
Technische Universität DresdenCompletedModerate to Severe Atopic DermatitisGermany
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisGermany
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany
-
IpsenTerminatedModerate Upper Facial Lines | Severe Upper Facial LinesGermany
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisBelgium, Spain, Russian Federation, Germany, United States, Czechia, Peru, Poland, Estonia
-
Universitätsklinikum Hamburg-EppendorfRecruiting
-
Laserklinik KarlsruheCompleted
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
Amazentis SAproDERM GmbHCompleted
-
Fresenius Kabi SwissBioSim GmbHMerck KGaA, Darmstadt, GermanyCompletedPsoriasis | Moderate to Severe Plaque Psoriasis | Plaque Type PsoriasisUnited States, Canada, Czechia, Hungary, Russian Federation, Bulgaria, Mexico, United Kingdom, Poland, Germany, Estonia, France
-
IpsenRecruitingModerate to Severe Upper Facial LinesGermany, France
-
University of JenaUnknown
-
Mundipharma Research GmbH & Co KGCompletedModerate to Severe Idiopathic RLS With Daytime SymptomsSpain, Sweden, Germany
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, France, Germany, Netherlands, Poland, Spain, Turkey, United Kingdom
-
GlaxoSmithKlineCompleted
-
Technische Universität DresdenRecruitingModerate-to-severe Atopic DermatitisGermany
-
NovartisCompletedModerate to Severe HypertensionRussian Federation, Romania, Singapore, Spain, Germany, Philippines
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisUnited States, Hungary, Italy, Russian Federation, Germany, Czechia, Canada
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Taiwan, United Kingdom
-
Novartis PharmaceuticalsCompletedMild Moderate | or Severe Renal ImpairmentGermany
-
Delenex Therapeutics AGCompletedMild-to-moderate Psoriasis VulgarisAustria, Germany
-
RepliCel Life Sciences, Inc.Syreon Corporation; Innovacell Biotechnologie AG; PHARMALOG Institut für klinische... and other collaboratorsCompletedIntrinsic Aging of Skin | Skin Wrinkling | Solar Degeneration of SkinGermany
-
Charite University, Berlin, GermanyJanssen-Cilag G.m.b.HRecruitingDepression | Suicidal Ideation | Suicide, Attempted | Suicidal and Self-injurious Behavior | Depression Moderate | Depression SevereGermany
-
Charite University, Berlin, GermanyWyeth is now a wholly owned subsidiary of PfizerUnknownModerate to Severe Active Axial SpondyloarthritisGermany
-
Fresenius Kabi SwissBioSim GmbHCompletedModerate to Severe Rheumatoid ArthritisBulgaria, United Kingdom, Hungary, Czechia, Poland, Germany
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)Germany
-
Merz Pharmaceuticals GmbHCompletedSkin Diseases | Wrinkles | Physiological Stress | Nasolabial Folds | Disorder of AgingGermany
-
Mundipharma Research GmbH & Co KGCompletedModerate to Severe Pain Due to Diabetic PolyneuropathyGermany
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Belgium, Bulgaria, Estonia, France, Georgia, Germany, Hungary, Italy, Poland, Singapore
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.CompletedModerate to Severe Atopic DermatitisUnited States, Canada, Czechia, Germany, Poland
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, United Kingdom
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Poland, Russian Federation, United Kingdom
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom